Rani Therapeutics Holdings Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $17
Rani Therapeutics Holdings Inc:Oppenheimer初始覆蓋報告給予跑贏大市評級;目標價17美元。
Rani Therapeutics Holdings Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $17
Rani Therapeutics Holdings Inc:Oppenheimer初始覆蓋報告給予跑贏大市評級;目標價17美元。
譯文內容由第三人軟體翻譯。